喹夫拉朋鈉
中文名稱 | 喹夫拉朋鈉 |
---|---|
中文同義詞 | 喹夫拉朋鈉 |
英文名稱 | sodium 3-[1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)-3-tert-butylsulfanyl-indol-2-yl]-2,2-dimethyl-propanoate |
英文同義詞 | sodium 3-[1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)-3-tert-butylsulfanyl-indol-2-yl]-2,2-dimethyl-propanoate;1-[(4-Chlorophenyl)Methyl]-3-[(1,1-diMethylethyl)thio]-α,α-diMethyl-5-(2-quinolinylMethoxy)-1H-Indole-2-propanoic Acid SodiuM Salt;MK 591;Quiflapon SodiuM;QUIFLAPON SODIUM; MK-591; MK 591;QUIFLAPON SODIUM (MK591);MK-591 sodium |
CAS號(hào) | 147030-01-1 |
分子式 | C34H34ClN2NaO3S |
分子量 | 0 |
EINECS號(hào) | |
相關(guān)類別 | Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds |
Mol文件 | 147030-01-1.mol |
結(jié)構(gòu)式 |
喹夫拉朋鈉 性質(zhì)
儲(chǔ)存條件 | -20°C |
---|---|
溶解度 | DMSO : 50 mg/mL (82.08 mM; 需要超聲波)H2O : < 0.1 mg/mL (不溶) |
形態(tài) | 粉末 |
顏色 | 白色至米白色 |
Quiflapon sodium (MK591) and SB203580 are able to block SEB-induced human PBMC cell proliferation. Quiflapon sodium (MK591) down regulates three genes [for cathepsin L, IL-17 and guanylate binding protein (GBP)-2] that are up regulated by SEB. Quiflapon sodium (MK591) undergoes apoptosis within hours of treatment. Quiflapon sodium also induces rapid activation of the stress kinase, c-Jun N-terminal kinase (JNK), which plays an important role in the apoptosis process. Quiflapon sodium triggers apoptosis in prostate cancer cells without inhibition of PI3K-Akt, or ERK. Moreover, Quiflapon sodium and LY294002 exert synergistic effect in inducing apoptosis in prostate cancer cells. Quiflapon sodium (MK591) influences cAMP response element-binding protein but not Sp1.
Hyperoxia groups of mice treated with Quiflapon sodium (MK591) (20, 40 mg/kg) show alveolarization that resembles that of room air controls while untreated hyperoxia groups show definite evidence of aberrant alveolarization but no inflammation. Comparison of the Aβ-immunopositive areas between the placebo and Quiflapon sodium (MK591) (320 mg/kg)-treated group reveals a statistically significant reduction of the amyloid burden in the treated mice. Quiflapon sodium also has a significant reduction in brain levels of IL-1β. Mice treated with Quiflapon sodium show a statistically significant decrease in the steady-state levels of total CREB and its phosphorylated form at Ser133.
安全信息
更新日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱 | CAS號(hào) | 包裝 | 價(jià)格 |
---|---|---|---|---|---|
2024/11/08 | HY-50714 | Quiflapon sodium | 1 mg | 465元 | |
2024/11/08 | HY-50714 | 喹夫拉朋鈉 Quiflapon sodium | 147030-01-1 | 5mg | 950元 |